Fa-Chyi Lee

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

Medicine, Oncology, Pharmacology +16

Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer

Manish A. Shah, Zev A. Wainberg, Daniel V.T. Catenacci et al. · PLoS ONE · 2013 · 206 citations · Full text

Medicine, Oncology, Pharmacology +17

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer

Aparna R. Parikh, Fa-Chyi Lee, Linda Yau et al. · Clinical Cancer Research · 2018 · 61 citations · Full text

Medicine, Oncology, Pharmacology +16

A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers

Julie E. Bauman, Monte Shaheen, Claire F. Verschraegen et al. · Translational Oncology · 2014 · 31 citations · Full text

Medicine, Oncology, Pharmacology +13

MAVERICC, a phase 2 study of mFOLFOX6-bevacizumab (BV) vs FOLFIRI-BV with biomarker stratification as first-line (1L) chemotherapy (CT) in patients (pts) with metastatic colorectal cancer (mCRC).

Heinz‐Josef Lenz, Fa-Chyi Lee, Linda Yau et al. · Journal of Clinical Oncology · 2016 · 30 citations

Medicine, Oncology, Pharmacology +16